RRM1 Predicts Clinical Outcome of High-And Intermediate-Risk Non-Muscle-Invasive Bladder Cancer Patients Treated With Intravesical Gemcitabine Monotherapy

BMC Urology - United Kingdom
doi 10.1186/s12894-019-0497-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Humoral Immune Factor Changes in Group of Patients With Non-Muscle Invasive Bladder Cancer Treated With Intravesical Therapy.

Journal of the faculty of medicine baghdad
2017English

Multi-Institutional Analysis of Sequential Intravesical Gemcitabine and Mitomycin C Chemotherapy for Non–muscle Invasive Bladder Cancer

Urologic Oncology: Seminars and Original Investigations
OncologyUrology
2014English

Intravesical Coxsackievirus A21 Therapy for Non-Muscle Invasive Bladder Cancer

Bladder Cancer
OncologyUrology
2020English

RRM1 Expression and the Clinicopathological Characteristics of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine

OncoTargets and Therapy
OncologyPharmacology
2018English

Assessment of Recurrence and Progression Risk in Patients With Non-Muscle Invasive Bladder Cancer

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2016English

Systemic Inflammatory Markers and Oncologic Outcomes in Patients With High-Risk Non–muscle-Invasive Urothelial Bladder Cancer

European urology oncology
OncologyRadiologyUrologyNuclear MedicineImagingSurgery
2018English

Advances in Intravesical Therapy for the Treatment of Non-Muscle Invasive Bladder Cancer (Review)

Molecular and Clinical Oncology
Cancer ResearchOncology
2014English

Editorial on the Value of an Immediate Intravesical Instillation of Mitomycin C in Patients With Non-Muscle-Invasive Bladder Cancer

Translational Andrology and Urology
Reproductive MedicineUrology
2018English

Collagen Stiffness Promoted Non-Muscle-Invasive Bladder Cancer Progression to Muscle-Invasive Bladder Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy